DaVita Stock: Is DVA Outperforming the Health Care Sector?

DaVita Inc. (DVA), headquartered in Denver, Colorado, provides kidney dialysis services for patients suffering from chronic kidney failure. Valued at $10 billion by market cap, the company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. 

Companies worth $10 billion or more are generally described as “large-cap stocks,” and DVA perfectly fits that description, with its market cap exceeding this mark, underscoring its size, influence, and dominance within the medical care facilities industry. DVA is a trusted leader known for quality care and innovation in kidney care. Its integrated approach offers services from diagnosis to transplant support, making it a comprehensive healthcare provider. Its focus on personalized care at scale has built strong patient trust and brand equity, solidifying its market dominance of over 25 years.